Alembic Pharmaceuticals Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

11:38 AM, 26th Jul 2025

Alembic Pharmaceuticals receives USFDA Final approval for Carbamazepine Extended-Release Tablets USP 100 mg 200 mg and 400 mg